Focusing on chronic ailment segments like diabetes, introduction of line extension for its flagship product Zincovit, getting regulatory approvals for its plants to export to Europe, US and other markets are some of the plans of Apex Laboratories to touch a turnover of Rs 750 crore by March 2021, said a senior company official.